Larvol Delta - atai-Life-Sciences-and-Beckley-Psytech-Announce-US-FDA-Breakthrough-Therapy-Designation-Granted-to-BPL003-Underscoring-its-Potential-in-TreatmentResistant-Depression

5-methoxy-dimethyltryptamine dry-powder intranasal (BPL-003) - Beckley Psytech

https://www.globenewswire.com/news-release/2025/10/16/3168328/0/en/atai-Life-Sciences-and-Beckley-Psytech-Announce-U-S-FDA-Breakthrough-Therapy-Designation-Granted-to-BPL-003-Underscoring-its-Potential-in-Treatment-Resistant-Depression.html

Oct 16, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next